Chandra Bhagat Pharma share news, announcements and annual reports
BSE: 542934Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 27 Oct 2026. Previous close ₹42.90.
27 Oct: open ₹42.90, high ₹42.90, low ₹42.90
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹32 Cr3,869th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.45
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.98
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,000
Chandra Bhagat Pharma share news and announcements
145 announcements, routine notices left out, newest first. Page 2 of 3.
Jul 2024
May 2024
30 May · Result As On March 31, 2024
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
29 Apr · Compliance Certificate Under Regulation 7(3) For Period Ended March 31, 2024.
29 Apr · Compliance Certificate Under Regulation 40(10).
Nov 2023
9 Nov · Results
2 Nov · Board meeting
Meeting on 9 Nov 2023: half yearly results
Sep 2023
30 Sep · Meeting
5 Sep · Board meeting
May 2023
15 May · Board meeting
Meeting on 22 May 2023: audited results
Apr 2023
Nov 2022
7 Nov · Board meeting
Meeting on 14 Nov 2022: half yearly results
Oct 2022
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Oct · Meeting
3 Oct · Meeting
1 Oct · Meeting
Sep 2022
6 Sep · Reg. 34 (1) Annual Report.
6 Sep · Meeting
6 Sep · Meeting
6 Sep · Board meeting
Jul 2022
20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
26 May · Board meeting
26 May · Board meeting
17 May · Board meeting
Meeting on 26 May 2022: audited results
Apr 2022
29 Apr · Compliance Certificate For The Period Ended 31St March, 2022.
19 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
31 Mar · Management
Jan 2022
18 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 05 Jan · Management
Nov 2021
19 Nov · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....19 Nov · Meeting